Followers | 31 |
Posts | 3397 |
Boards Moderated | 0 |
Alias Born | 02/09/2017 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, November 19, 2021 3:56:30 PM
Recent IOBT News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:06:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 11:05:59 AM
- IO Biotech Reports Second Quarter 2024 Financial Results and Provides Business Highlights • GlobeNewswire Inc. • 08/13/2024 11:05:00 AM
- IO Biotech Announces New Head and Neck Cohort Data Accepted for Presentation at ESMO Congress 2024 • GlobeNewswire Inc. • 07/25/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 08:44:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:18:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:14:19 PM
- IO Biotech to Present at Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/23/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 12:30:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 12:13:53 PM
- IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights • GlobeNewswire Inc. • 05/14/2024 11:55:00 AM
- IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 04/24/2024 08:30:00 PM
- IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness • GlobeNewswire Inc. • 04/15/2024 12:30:00 PM
- IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103 • GlobeNewswire Inc. • 04/09/2024 04:00:00 PM
- IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer • GlobeNewswire Inc. • 04/05/2024 12:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/11/2024 08:56:44 PM
- IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 03/06/2024 09:11:01 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 10:17:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:46:56 PM
- IO Biotech Announces 2023 Fourth-Quarter and Year-End Results • GlobeNewswire Inc. • 03/05/2024 09:40:01 PM
- IO Biotech to Present at 44th Annual Cowen Health Care Conference • GlobeNewswire Inc. • 02/26/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:11:55 PM
- IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial • GlobeNewswire Inc. • 12/21/2023 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/24/2023 10:37:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:15:37 PM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM